Baird Financial Group, Inc. - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 77 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baird Financial Group, Inc. ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$2,586,000
+6705.3%
500,113
+4901.1%
0.01%
Q2 2021$38,000
-95.9%
10,000
-94.3%
0.00%
-100.0%
Q3 2018$933,000
+6.5%
174,088
+0.8%
0.01%0.0%
Q2 2018$876,000
-23.5%
172,738
+2.9%
0.01%
-25.0%
Q1 2018$1,145,000
+140.0%
167,917
+165.6%
0.01%
+166.7%
Q4 2017$477,00063,2230.00%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 9,775,849$2,913,2031.93%
Aquilo Capital Management, LLC 3,303,190$984,3510.89%
CM Management, LLC 649,400$193,5210.20%
BVF INC/IL 20,609,863$6,141,7390.17%
WEALTH EFFECTS LLC 11,700$3,4870.00%
NJ State Employees Deferred Compensation Plan 30,000$8,9400.00%
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV 14,000$4,1720.00%
ACADIAN ASSET MANAGEMENT LLC 962,358$2860.00%
TWO SIGMA ADVISERS, LP 24,400$7,2710.00%
Tower View Wealth Management LLC 1,000$00.00%
View complete list of PIERIS PHARMACEUTICALS INC shareholders